Eileen Kennedy awarded $1.46 million grant for her work on LRRK2 inhibitors

Congratulations to Dr. Eileen Kennedy, Dr. Samuel C. Benedict Professor in the department of pharmaceutical and biomedical sciences at the College of Pharmacy, who has received notice from the Michael J. Fox Foundation for Parkinson’s Research that her grant titled, “Biochemical and Structural Characterization of the LRRK2 Activation Cycle to Develop LRRK2 Inhibitors,” has been funded for $1.46 Million.  Dr. Kennedy is a PI on this grant, which represents an international team including The German Center for Neurodegenerative Diseases and The University of Groningen in the Netherlands.